Viz.ai Launches AI-Powered Viz™ Vascular Suite
Press & NewsEnd-to-end platform for vascular care teams to accelerate the detection and treatment of suspected vascular disease SAN FRANCISCO – January...
Jan 12, 2023
Explore our News & Press
End-to-end platform for vascular care teams to accelerate the detection and treatment of suspected vascular disease SAN FRANCISCO – January...
Jan 12, 2023
Healthcare technology leader recognized for its culture, diversity, career growth and outlook SAN FRANCISCO - December 15, 2022 - Viz.ai,...
Dec 15, 2022
New partnership incorporates latest perfusion technology into the Viz.ai platform SAN FRANCISCO - November 29, 2022 - Viz.ai, the leader in AI-powered...
Nov 30, 2022
Comprehensive solution tailored for radiologists to expedite patient diagnosis and treatment SAN FRANCISCO - November 28, 2022 - Viz.ai, the leader...
Nov 28, 2022
Leading experts to help shape the future of Viz.ai’s radiology strategy and platform SAN FRANCISCO - November 28, 2022- Viz.ai,...
Nov 28, 2022
Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value. SAN FRANCISCO & NEW YORK--(BUSINESS...
Nov 18, 2022
Partnership to accelerate enrollment and diversity in neurovascular clinical research. SAN FRANCISCO - November 16, 2022 - Viz.ai, the leader in...
Nov 16, 2022
Adds natural language processing to Viz.ai’s AI-powered platform to detect suspected disease earlier and monitor patients. SAN FRANCISCO – November 15,...
Nov 15, 2022
Median size of aneurysms was 5mm, suggesting that AI-powered detection of incidental cerebral aneurysms can improve patient care pathways. SAN...
Nov 10, 2022
Comprehensive solution tailored for cardiovascular care teams to improve care pathways and grow referrals CHICAGO & SAN FRANCISCO--(BUSINESS WIRE)--AMERICAN HEART...
Nov 04, 2022
Partnership delivers critical insights to cardiac care teams for faster patient triage and care. SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in...
Nov 02, 2022
AngioDynamics, The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients...
Oct 31, 2022